ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Safeguarding Cell Therapy Cryopreservation: Primary Containers

  Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.

• Navigating Audit Trail Data Regulations And Accessibility Changes

  Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.

• Building A Global Cell And Gene Supply Chain Serving Personalized Medicine

  Clinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.

• Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials

  Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.

• Using Tech Enabled Solutions To Boost Productivity And Sustainability

  How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• Prefillable Syringe Plungers: A Solution For Low Temperature Storage

  Review a study with 1 mL long glass and polymer-based syringes and with 2.25 mL glass syringes. Explore the impacts on plunger movement, container closure integrity, and break loose and extrusion force.

• Building Better Resilience Into Your Clinical Supply Strategy

  Reliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.

• Outsourcing Your Highly Potent Oncology Drug Product

  Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.

• Transforming The Pharma Supply Chain

  Start leveraging logistics partners with global end-to-end solutions that can help avoid costly delays, ensure high product quality, and accelerate impactful solutions for patients worldwide.